Outcomes after alloSCT for R/R HL with or without prior anti-PD1 CPI. Color gradients indicate differences between the 2 settings, with green indicating improved outcomes and red indicating poorer outcomes for the respective measure. ∗Without posttransplantation cyclophosphamide. aPD1, anti-PD antibody.